Could a drug combo cure hepatitis b in kids? new trial aims to find out
NCT ID NCT07345624
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving two antiviral drugs—entecavir followed by pegylated interferon—can help children aged 3 to 6 with chronic hepatitis B achieve a functional cure (clearing the virus from the blood). About 80 children will be randomly assigned to receive either entecavir alone or entecavir plus the second drug. The goal is to see if the combination leads to better long-term virus control and possible cure, though lifelong monitoring may still be needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Hidden heart risks in Wilson's disease: a new scan could spot them early
- Can a new formula save more children from severe malnutrition?
- Can a new sedative combo make Children's gastroscopy safer?
- Could a buzzing device make childhood shots painless?
- Can a new injection tame chronic hepatitis b?